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Abstract
Background: Depression and hypertension are common, costly, and destructive conditions among the rapidly
aging population of China. The two disorders commonly coexist and are poorly recognized and inadequately
treated, especially in rural areas.
Methods: The Chinese Older Adult Collaborations in Health (COACH) Study is a cluster randomized controlled trial
(RCT) designed to test the hypotheses that the COACH intervention, designed to manage comorbid depression and
hypertension in older adult, rural Chinese primary care patients, will result in better treatment adherence and greater
improvement in depressive symptoms and blood pressure control, and better quality of life, than enhanced Care-as-
Usual (eCAU). Based on chronic disease management and collaborative care principles, the COACH model integrates
the care provided by the older person’s primary care provider (PCP) with that delivered by an Aging Worker (AW) from
the village’s Aging Association, supervised by a psychiatrist consultant. One hundred sixty villages, each of which is
served by one PCP, will be randomly selected from two counties in Zhejiang Province and assigned to deliver eCAU or
the COACH intervention. Approximately 2400 older adult residents from the selected villages who have both clinically
significant depressive symptoms and a diagnosis of hypertension will be recruited into the study, randomized by the
villages in which they live and receive primary care. After giving informed consent, they will undergo a baseline research
evaluation; receive treatment for 12 months with the approach to which their village was assigned; and be re-evaluated
at 3, 6, 9, and 12 months after entry. Depression and HTN control are the primary outcomes. Treatment received, health
care utilization, and cost data will be obtained from the subjects’ electronic medical records (EMR) and used to assess
adherence to care recommendations and, in a preliminary manner, to establish cost and cost effectiveness of the
intervention.
Discussion: The COACH intervention is designed to serve as a model for primary care-based management of common
mental disorders that occur in tandem with common chronic conditions of later life. It leverages existing resources in
rural settings, integrates social interventions with the medical model, and is consistent with the cultural context of rural
life.
Trial registration: ClinicalTrials.gov ID: NCT01938963; First posted: September 10, 2013.
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Background
China’s population of older adults is growing rapidly. Esti-
mates are that by 2015 there will be over 140 million
people in China over age 65 years—equivalent to 44% of
the total U.S. population (U.S. Census). The prevalence of
affective illness among older adults is significant. Almost
6% of community-dwelling Chinese over age 60 have a de-
pressive disorder [1, 2]. Among those with chronic med-
ical conditions, the prevalence of depression is higher,
about 13% [3]. Depression is associated with functional
impairment, greater use and higher costs of healthcare,
and increased risks of suicide and all-cause mortality [4].
Hypertension (HTN) is one of the most common chronic
conditions in China, estimated to have affected 57% of rural
village residents over age 60 [5]. HTN is a major cause of
strokes and ischemic heart disease [6], which is the only
disorder to top depression in the WHO’s list of greatest
expected causes of global illness burden by 2020 [7].
Depression and HTN commonly coexist [3, 8, 9]. A
study in Shanghai shows that over 78% of medical inpa-
tients with HTN had clinically significant depressive symp-
toms [10]. The combination of HTN and depression
complicates treatment; for example, depression may affect
patients’ hypertension medication adherence. However,
there is low recognition of the need to treat depression in
China [10, 11], and mental health care in general is difficult
to access, especially in rural areas. Primary care providers
(PCP) in rural villages of China are charged with managing
their patients’ chronic conditions, including HTN, but they
receive little or no training in diagnosis or treatment of
mental illnesses and are not permitted to prescribe
antidepressants.
Approaches to management of depression [12–14] and
comorbid medical conditions [14, 15] in primary care set-
tings have been developed and well tested in Western na-
tions. Based on the chronic disease management model
[16], they typically include the use of algorithm-driven,
evidence-based depression treatments administered by the
PCP in collaboration with a depression-care specialist
(nurse, psychologist, social worker) who is embedded in
the practice and supervised by a psychiatrist; regular symp-
tom monitoring; and education and support of patients
and families to ensure their active engagement in care. This
integrated or collaborative depression care management
approach has been associated with improved clinical out-
comes as well as cost savings relative to care-as-usual
(CAU), including in older adults [14, 17]. It has rarely been
applied in developing nations like China, however. One ex-
ception is a randomized controlled trial of collaborative de-
pression care management among older adults in urban
primary care clinics conducted by our group, the results of
which showed significantly greater reductions of depressive
symptoms over 12 months when compared with patients
who received CAU [18]. No RCTs have examined the
effectiveness of integrated depression care management in
rural China, where access to care is more challenged, none
has addressed depression comorbid with other common
chronic conditions such as HTN, and none has comple-
mented medication management with a psychosocial treat-
ment component, which is often a preferred option of
older adult Chinese [19].
Our objective with this study is to address these short-
comings of previous work. Using a cluster randomized con-
trolled design, the Chinese Older Adult Collaborations in
Health (COACH) Study will compare the COACH inter-
vention to enhanced Care-as-Usual (eCAU) for the treat-
ment of comorbid depression and HTN in older residents
of rural Chinese villages. COACH integrates the care pro-
vided by a PCP with that delivered by an Aging Worker
(AW, a staff person of either the Women’s Federation or
Aging Association of the village), and supervised by a
psychiatrist consultant (Psychiatrist). The study’s five aims
are designed to test the hypotheses that, relative to subjects
who receive eCAU, those in the COACH intervention will
show (Aim 1a) better adherence to antidepressant treat-
ment recommendations and (Aim 1b) greater improve-
ments in their depressive disorders over 12 months of
involvement in the study; and further that relative to sub-
jects who receive eCAU, those in the COACH intervention
will show (Aim 2a) better adherence to antihypertensive
treatment recommendations and (Aim 2b) greater im-
provements in blood pressure (BP) control. We will exam-
ine the temporal associations of change in depression and
BP control, hypothesizing that (Aim 3a) improvements in
treatment adherence precede symptomatic improvement in
depression and hypertension, (Aim 3b) improvements in
depression will precede improvements in BP control, and
(Aim 3c) those temporal patterns are associated with the
intervention received. We hypothesize also that the
COACH intervention results in greater improvements in
health-related quality of life than eCAU (Aim 4). Finally
(Aim 5), we will explore resource utilization and costs asso-
ciated with delivering the eCAU and the COACH interven-
tions over 12 months, important information with which to
guide subsequent research on implementation and dissem-
ination of the model if it is shown to be clinically effective.
Methods
Setting
This ongoing study is being conducted in rural villages
of Tonglu and Jiande counties, two of 55 counties in
Zhejiang Province, China. With population size and
average household income at the mean level of all coun-
ties in Zhejiang Province, Tonglu and Jiande encompass
283 and 319 villages respectively, with average popula-
tions of 1400 and 1600. Approximately 20% of their pop-
ulations are age ≥ 60 years. They are served by a total of
602 PCPs (one in each village) and two mental hospitals
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(one for each county), which combined have 19 psychia-
trists who serve 0.72 million village residents. Every
village has either a Women’s Federation or an Aging
Association that is staffed by local residents, one of
whom is the designated AW.
Sample strategy and procedures
As a guard against bias associated with “leakage” of the
intervention across arms of the study, the unit of
randomization is the village, which is equivalent to clinic-
level randomization. Of all villages in Tonglu and Jiande
County 160 have been randomly selected by Prof. Hengjin
Dong to receive either the eCAU or COACH. No two vil-
lages assigned to different intervention arms (COACH or
eCAU) are geographically contiguous. Upon random se-
lection of each village, each PCP and AW are approached
by the study coordinator and their county-level supervi-
sors for agreement to participate. If any PCP or AW
declines, or if their assignment places them immediately
adjacent to a village in which the other intervention is to
be offered, another village will be selected from the pool.
Subjects
A total of approximately 2400 subjects will be recruited to
participate in the study for up to 12 months. They will in-
clude registered residents who live independently in the se-
lected villages in Tonglu or Jiande County. They must be
≥60 years and have both clinically significant depression,
defined as a baseline score on the Patient Health
Questionnaire-9 (PHQ-9) [20] of 10 or more, and a diag-
nosis of HTN in their medical record. Subjects must have
intact cognitive functioning (Six-Item Screener [SIS] [21]
score < 3) and be capable of participating in study inter-
views with informed consent. Subjects found on baseline
assessment to have mania, psychosis, alcohol abuse or de-
pendence active in past 6 months, or suicidal ideation with
intent are excluded from the study with a recommendation
made to the PCP that they be referred for psychiatric
assessment at the County Mental Hospital.
Procedure for recruitment, consent and retention
Each village clinic has a standardized electronic medical
record system (EMR) supported by the Zhejiang Center for
Disease Control and Prevention (CDC) in which each pa-
tient is registered. PCPs use the EMR to identify all village
residents age ≥ 60 years who have a diagnosis of HTN.
Trained in the administration of the PHQ-9, they then visit
each potential subject, either in their home or the village
clinic, and administer the PHQ-9. Those who screen posi-
tive are invited to meet with the research assistant (RA)
who introduces him or her to the study, obtains written in-
formed consent, and conducts the baseline research assess-
ment. RAs return to the village 3, 6, 9, and 12 months later
to conduct follow up research interviews. The subjects’
involvement in the study ends after 12 months.
Comparison condition: Enhanced Care-as-Usual (eCAU)
PCPs in village clinics have on average three years of med-
ical education after completing high school. They receive
systematic training in the diagnosis and treatment of com-
mon chronic medical illnesses. For HTN management they
are expected to follow guidelines developed by the Center
for Disease Control and Prevention in China, [21] which is
analogous to those developed by the U.S. Joint National
Committee on Prevention, Detection, Evaluation, and
Treatment of High Blood Pressure (the “JNC 7 Report”
[22]). The guidelines address detection, management by
both pharmacologic and non-pharmacologic means, and
guidance on when to refer to more specialized care.
Village PCPs, however, receive little training in the diag-
nosis or treatment of mental disorders and ordinarily are
provided with no practice guidelines to help with its man-
agement. When depression is suspected by PCPs, current
practice involves suggesting to patients (or family mem-
bers) that they consult a psychiatrist at the County Mental
Hospital for diagnosis and treatment. There is no direct
referral/transfer mechanism between PCPs and mental
health specialists, and it is uncommon for patients to take
the initiative. Provincial laws prohibit the village PCP from
initiating antidepressant treatment. However, if the patient
does see the County Mental Hospital psychiatrist who
then begins antidepressant medication, the PCP may
choose to renew the prescription, typically in two-week
increments.
We refer to CAU as “enhanced” (eCAU) because PCPs
are told when study subjects screen positive for depres-
sion and are provided with copies of depression practice
guidelines developed for the study. Because of con-
straints on their knowledge and practice, however, we do
not anticipate that access to this information will sub-
stantially impact patient outcomes [23–27].
Intervention: COACH
The COACH intervention applies chronic disease man-
agement principles to the treatment of both depression
and HTN by a team consisting of the village PCP, AW,
and a Psychiatrist.
Primary care providers (PCP)
The background and qualifications of the PCP are as de-
scribed above for eCAU. The PCP’s role and responsibilities
in COACH include screening and ongoing monitoring of
blood pressure and depressive symptoms with the PHQ-9,
management of depression and HTN using standardized
practice guidelines in collaboration with other COACH
team members, and education of the patient, family and
community about these chronic conditions.
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Aging Workers (AW)
A staff member of either the village’s Women Federation
or Aging Association is designated as the AW for the
COACH team. S/he typically has a middle-school educa-
tion, knows the residents well, and is well connected with
the village leadership. Although the AWs have no special
training in social work, they receive in-service training
from the Bureau of Civil Affairs and have experience in
addressing the villagers’ social needs. Their responsibilities
for the COACH intervention include baseline and
ongoing assessment of social stressors and supports,
fostering social connectedness, behavioral activation,
adherence support, facilitating communications with the
PCP, and education of the patient, family and community
about depression and HTN and their management.
Psychiatrist
Each COACH team is linked with one of the psychia-
trists based at the Tonglu and Jiande County Mental
Hospital. These two hospitals have a full array of in-
patient (40 and 42 beds respectively) and outpatient ser-
vices. Psychiatrists have on average 5 years of medical
training after high school followed by 2 years of specialty
training. Their scope of practice includes psychiatric
diagnosis and management of patients of all ages with
mental illness from across the county. Their role in
COACH is to provide baseline diagnosis and initial pre-
scription of depression treatment, and to provide on-
going consultation to the team in its algorithm-driven
management of the patient’s illness.
Training requirements and procedures
Following randomization, PCPs and AWs of villages
assigned to implement COACH undergo training at the
County Mental Hospital along with the Psychiatrist con-
sultant. Each member of the COACH team requires
training in their individual role, and all require training
in how to work together collaboratively.
The intervention as outlined in the curriculum for the
PCPs includes four major components: (a) depression man-
agement guidelines adapted from the Duke Somatic Treat-
ment Algorithm for Geriatric Depression (STAGED) [28]
and applied in our prior study of depression care manage-
ment in urban Hangzhou clinics [18]; (b) hypertension
management using the guidelines adopted by the primary
care system in China [21]; (c) case management using the
toolkit adapted from the MacArthur Initiative on Depres-
sion in Primary Care [21, 29]; and (d) psychoeducation (PE)
and communication skills. PCP training is administered
over 4 days. There are no restrictions on concomitant care
or treatment,
The AW curriculum, administered over 3 days, includes:
(a) an overview of depression, HTN, and their relation-
ship; (b) self-management of depression and hypertension;
(c) social environment as risk and protective factors; (d)
conducting psychosocial assessment and developing a care
plan; (e) providing psychoeducation to subjects and their
families; (f) techniques to reinforce treatment adherence
and healthy lifestyles; (g) communication and problem-
solving skills with older adults and their families; (e) eth-
ical standards including confidentiality.
Finally, PCPs, AWs and Psychiatrists come together
for 1 day to learn how to collaborate in care manage-
ment. They are taught about the roles of the other team
members and review procedures guiding their communi-
cations and information transfer. Instruction techniques
include structured didactics, role-plays, and process/
problem solving sessions exploring potential barriers to
communication and collaboration.
PCPs, AWs, and Psychiatrists in the COACH study arm
and PCPs in eCAU villages receive a small salary stipend
from the Departments of Health of Tonglu and Jiande
counties for their added effort in support of the study.
Procedures guiding team implementation of COACH
With initiation of the study the PCP meets with each sub-
ject to review management of their BP. The Psychiatrist
travels to the village and conducts the assessment to estab-
lish the depression diagnosis in the subject’s home or the
village clinic according to the subject’s preference. S/he
then consults with the PCP and, if medications are indi-
cated, initiates treatment with an antidepressant according
to the study’s treatment guidelines. The AW visits the sub-
ject in his or her home to conduct a systematic assessment
of the person’s functional status, social supports, lifestyle,
medication use, nutritional and financial status. The AW
and PCP then meet, review the findings of the AWs in-
home assessment and the patient’s physical and mental
health, and construct a care plan (problem list, approach
to each problem, responsible person, target date for com-
pletion) that addresses social, physical, and mental health
needs in a coordinated fashion.
The PCP continues to meet with the patient at the inter-
vals designated by the HTN and depression practice guide-
lines, monitoring progress with repeated PHQ-9 and BP
measures and adjusting treatment as indicated. The AW
continues to work with the subject to address identified
problems; educate the subject and family about their
illnesses and support adherence to depression and hyper-
tension treatment regimens; encourage good health behav-
iors (diet, exercise, smoking cessation) based on established
psychoeducation methods; and connect the patient to
others and to the community (e.g., engage in social groups,
visits with friends and family). These activities can be
through working with individuals (e.g., home visits with the
subject and family), small groups (e.g., cooking demonstra-
tions, Tai Chi class), and community events (e.g., commu-
nal meals, games.) AW outreach to the subject continues
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weekly for 2 months, then biweekly for 2 months, then
monthly. If the patient continues to require AW support,
more frequent visits are conducted.
The PCP and AW are instructed to meet weekly to re-
view their shared caseload. Each patient is very briefly
discussed and the treatment plan updated as indicated.
The Psychiatrist is available by telephone to make add-
itional suggestions regarding depression management,
and may refer the patient to the County Mental Hospital
as needed to assure safety.
Study measures and procedures
Study measures are administered in face-to-face interviews
conducted in the subject’s home or the clinic by unblinded,
trained research assistants at study entry and 3-, 6-, 9-, and
12-months later. Data will be transferred from hard copy
forms by duplicate entry to the electronic data base and
maintained in secure servers at the Zhejiang University.
Reasons for dropout and any occurence that could consti-
tute an adverse event will be documented by the research
interviewers, examined by the study investigators, and re-
ported as indicated to the study’s institutional review
boards. As well, they will be assessed in semi-annual meet-
ings of the study’s Data and Safety Monitoring Board
(DSMB) that is composed of Chinese experts independent
from the sponsor and competing interests.
The measures we obtain fall into three domains: socio--
demographic and baseline characteristics, outcome vari-
ables, and covariates that may independently influence
adherence and treatment response. The timing of their
administration is depicted in Table 1.
Socio-demographic characteristics include age, sex,
education and literacy level, and marital status. During
the baseline interview we use the Mini-International
Neuropsychiatric Interview (MINI) [30] to assess for the
presence in the last 6 months of mania, psychosis, and
alcohol misuse, which are exclusion criteria. If a ques-
tion of suicide risk is raised, the study’s safety protocol is
implemented and a decision made whether the subject
should be excluded from the study.
Our primary outcome variables are adherence to anti-
depressant and antihypertensive medication recommenda-
tions, depression symptom severity, and BP control.
Adherence is measured both by self-report (a single ques-
tion inquiring whether the subject has missed any doses
of her/his medications in the past) and by construction of
a Medication Possession Ratio (MPR) from prescriptions
written and filled, based on the patient’s EMR. The MPR
then is calculated as the ratio of the total days of medica-
tion supplied to total days in a period [31], with values
≥80% considered medication adherent [32]. The MPR is
an accepted metric for the evaluation of adherence using
retrospective data, including in China [33].
The measure of depressive symptom change will be the
Hamilton Depression Rating Scale – 17 item version
(HDRS), which is widely used, reliable and valid in Chin-
ese [34]. Consistent with other geriatric depression studies
[35] and our own work [36], we define response to treat-
ment as a change in the HDRS score > 50% from baseline,
and remission as a follow-up HDRS score lower than 7.
BP control is established at follow up using guidelines
specified by the Hypertension Treatment Guidelines [21,
22]. BP is taken according to the standards developed by
the Center for Disease Control and Prevention in China
(auscultation with cuff deflation method after seated
quietly for 5 min in the proper position; no caffeine, ex-
ercise or smoking in preceding 30 min; appropriately
sized cuff; average of three measurements is recorded.)
For analyses, uncontrolled HTN is defined as systolic
BP ≥ 130 or diastolic BP ≥ 80 for patients with diabetes
mellitus, coronary heart disease or renal disease, and
BP ≥ 140 or diastolic BP ≥ 90 for all others [21, 22].
Table 1 Timeline of measures
Measure AIM Baseline 1 months 3 months 6 months 9 months 12 months
HDRS, PHQ-9 x x x x x x
BP x x x x x x
MPR x x
WHOQOL-BREF x x x
BMI x x
CCI x x
ADL, IADL x x x
MOS-SSS-C, SNS x x x
CSQ-8 x x
PS x x
Cost data (EMR) x x
Notes: ADL activities of daily living, BMI body mass index, BP blood pressure, CCI Charlson Comorbidity Index, CSQ-8 Client Satisfaction Questionnaire 8-item, EMR
electronic medical record, HDRS Hamilton Depression Rating Scale, IADL instrumental activities of daily living, MOS-SSS-C, Medical Outcomes Study Social Support
Survey, MPR medication possession ratio, SNS Social Network Size, PS Perceived Stigma Scale, WHOQOL-BREF WHO Quality of Life-BREF
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Quality of life is measured using the WHOQOL-BREF
[37, 38], a 26 item scale that yields four domain scores -
physical, psychological, social and environment - each of
which we will examine separately in analyses. The
WHOQOL-BREF is a widely used measure the Chinese
version of which has shown very good psychometric prop-
erties [39–41].
In exploratory analyses we will estimate the costs associ-
ated with two components of the intervention: (a) the in-
cremental costs of adding COACH resources to eCAU
(programmatic costs), and (b) medical costs attributable to
the care of the subjects in each arm. Programmatic costs
will include expenses associated with training, travel for
consultant psychiatrists between Tonglu/Jiande and the vil-
lages for the intake assessment, staff time for intervention
team meetings, and any information system costs. Medical
costs include costs of medical treatment documented by
the subjects’ EMR and Zhejiang Province insurance data
that document each office visit, drug prescription, labora-
tory test performed, or hospital stay for medical or mental
health reasons. As well, we will include patient out-of-
pocket healthcare costs in the preceding 3-month interval
obtained by subject interview at each research assessment
point. Cost data will be converted to US dollars.
Additional variables for use as covariates in analyses in-
clude factors known to influence adherence, treatment re-
sponse or both, include the Charlson Comorbidity Index
[42] adapted for use with ICD-9 codes [43] and supple-
mented by questions about common disabling conditions
of late life including diabetes, high cholesterol, heart dis-
ease, and stroke; and the Body Mass Index (BMI), which
is associated with hypertension treatment response. As a
measure of functioning independent of the WHOQOL-
BREF physical domain score, we measure the subject’s im-
pairment in basic (ADL) and instrumental activities of
daily living (IADLs) [44] and cognitive function with the
Six-Item Screener (SIS) [45, 46]. We measure social sup-
port with the Chinese version of the Medical Outcomes
Study Social Support Survey (MOS-SSS-C) [47] and social
network size (total number of persons with whom the
respondent has discussed important matters in the past
6 months) [48]. Participants will be queried about side ef-
fects of both their antidepressant and antihypertensive
medications using the Antidepressant Side-Effect Check-
list [49] and the Side-Effects and Symptoms Distress
Checklist [50] respectively.
Sample size estimate
Primary outcomes of the COACH Study on which sam-
ple size estimates were based are (1) adherence to
depression and HTN treatment (MPR and % of subjects
with 80% MPR); (2) depression symptom change (pro-
portion with 50% reduction in HDRS and % with HDRS
< 10); and (3) HTN control (% with BP controlled).
Additional assumptions on which selection of the esti-
mated sample of 2400 from villages randomized by village
to the COACH or eCAU conditions was based include an
attrition rate of 20% over 12 months, informed by our pre-
vious studies in Hangzhou. Since the village-randomized
study is a 3-level nested longitudinal design, power de-
pends on the intra-class correlation (ICC) among the pa-
tients within the PCP and serial correlation between
repeated assessments within the patient. We set the serial
correlation at 0.5, but varied the ICC over 0.05, 0.1 and 0.
2 to get a sense of the impact of the latter on power. Based
on two-sided type I error = 0.05, power = 0.8 and an attri-
tion rate of 20%, the detectable effect size ranged from 0.
17 to 0.26 for a continuous outcome. Since experiences
with multi-level designs suggest that ICC is generally
smaller than 0.2, the study is sufficiently powered to detect
small effect sizes between the two intervention groups.
For the dichotomous outcomes, we also set the serial cor-
relation at 0.5 and varied the percent of variance between
patients within the PCP over 0.05, 0.1 and 0.2. Based on
two-sided type I error = 0.05, power = 0.8, base rate 0.5
(most conservative) and an attrition rate of 20%, the de-
tectable between-group proportion ranged from 11 to
17%, which is well within the range of clinically meaning-
ful differences in the primary care setting.
Statistical analytic approach
Descriptive statistics (counts and proportions for categor-
ical variables and means [± SD] for continuous outcomes)
will be used to depict the characteristics of the sample (e.g.,
age, gender, physical and functional status). We will com-
pare baseline characteristics between groups using t-test
(for continuous variables) and chi-square (for discrete
variables), and examine associations between outcome
variables and patients’ characteristics. Characteristics
significantly differentiating the two groups will be treated
as covariates when testing between-group differences using
longitudinal models and structural equation models (SEM).
Aim 1 – Depression
We hypothesize that relative to subjects who receive eCAU,
those in the COACH intervention will show (a) better ad-
herence to antidepressant treatment recommendations and
(b) greater improvements in their depressive disorders over
12 months of involvement in the study. We will model each
repeatedly assessed variable of adherence to depression
treatment as well as improvement in depression using gen-
eralized linear mixed effect models (GLMM) and weighted
generalized estimating equations (WGEE), two common
approaches for modeling treatment differences over time
[51]. Both approaches provide valid inference in the pres-
ence of missing data if the missing value follows the missing
at random (MAR) assumption, a popular mechanism that
applies to most studies in practice [51]. If estimates differ
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between the two approaches, only WGEE results will be re-
ported, as it provides significantly more robust inference,
especially in the presence of missing data [51, 52]. We will
perform intention-to-treat analyses using all subjects ran-
domized to the treatment groups.
For each outcome, time and intervention will be predic-
tors, adjusting for covariates. We will also assess the poten-
tial interaction between time and intervention. To avoid
oversimplifying temporal patterns with linear trend, we will
use piece-wise or even polynomial functions of time based
on the assessment points. Linear contrasts will be used to
assess COACH vs. eCAU differences over the 12-month
period as well as any sub-intervals within this period.
Aim 2 – Hypertension
We hypothesize that relative to subjects who receive
eCAU, those in the COACH intervention will show (a)
better adherence to antihypertensive treatment recom-
mendations and (b) greater improvements in BP control.
The same approach as Aim 1 will be used to examine
the hypotheses in this Aim.
Aim 3 – Temporal associations
We will examine the temporal associations of change in
depression and BP control, hypothesizing that (a) im-
provements in treatment adherence precede improve-
ment in depression and hypertension, and (b)
improvements in depression will precede improvements
in BP control. The dynamic relationships between adher-
ences, improvement in depression and BP control and
mediation of the intervention effect on BP control by
improvement in depression will be examined using
SEM. We will first examine the causal, or meditational,
relationship between the COACH intervention, adher-
ence to antidepressant (antihypertensive) medications
and improvement in depression (BP control), using SEM
with intervention as the predictor, adherence as the me-
diator and depression (BP control) as the outcome. To
ensure the temporal order that changes in adherence
take place before improvements in depression (BP con-
trol), the depression (BP control) variable will lag by one
visit with respect to the adherence variable. We will con-
struct direct, indirect, and total effects, and perform
tests to see if adherence to antidepressant (antihyperten-
sive) medications mediates the effect of the intervention
on improvement in depression (BP control).
The same approach will be used to test the mediation
hypothesis in (b), where depression is the mediator and
BP control is the outcome.
Aim 4 – Health-related quality of life
In addition to its impact on depression and BP control,
we will ask whether the COACH intervention results in
greater improvements in health-related quality of life
than eCAU. We will use the same approach as in Aim 1
to test the hypothesis. The longitudinal model will be
applied to each of the WHOQOL-BREF domain scores.
Aim 5 – Cost
Finally, we will determine resource utilization and costs
associated with delivering the eCAU and the COACH
interventions over 12 months and, in a set of exploratory
analyses, conduct an economic feasibility evaluation
using cost-effectiveness analysis (CEA) and cost-benefit
analysis (CBA) methods. We consider them exploratory
because the 12-month duration of the intervention is
relatively short for such analyses.
For CEA we will calculate an incremental cost-effective-
ness ratio (ICER) based on two outcomes: (a) reduction in
the average HDRS score between the eCAU and COACH
subjects (ΔEffect = hypertension [eCAU] – hypertension
[Coach]); and (b) Increase in the proportion of patients
with controlled BP: ΔEffect = cBP(eCAU) – cBP(Coach).
The ICER will be interpreted as the incremental cost per
unit improvement in health as measured by the outcome
of choice (HDRS score or % of patients with BP control).
For CBA, the benefit of the intervention will be estimated
as the reduction in the average healthcare expenses
between the patients receiving eCAU and COACH
(ΔEffect =ΔBenefit =MedCost[CAU] – MedCost[Coach]).
The results of cost-benefit analysis could be interpreted as
the return on investment (ROI; the ratio of reduction in
medical costs to the incremental cost of the intervention,
with ratio > 1 indicating a significant return) or as a net
monetary benefit (NMB= the difference between the
reduction in medical costs and the incremental cost of the
intervention, NMB > 0 indicating a monetary benefit of the
intervention).
Discussion
The COACH study uses a cluster randomized controlled
trial design to compare an integrated, primary care-
based depression care management approach to eCAU
for the treatment of comorbid depression and HTN in
older adult Chinese rural village residents. Building on a
large body of research that has established the effective-
ness of integrated care models for depression and other
common mental disorders in Western countries, the
COACH study is one of very few to apply the model in
a low/middle income country (LMIC) in which mental
health resources are scarce and the need is enormous
and growing rapidly. With 150 million adults over age
65 currently, China’s older adult population is projected
to grow to over 400 billion by 2050, even as the relative
proportion of the working aged population decreases.
Rapid changes are underway in family structure with mi-
gration of younger and middle aged adults from rural to
urban centers for work, leaving their older adult parents
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behind in rural villages where the prevalence of depres-
sion is high and treatment is rarely accessible. Indeed,
this situation is common in the developing world.
Research is required on means by which to give primary
care clinics the tools with which to address the mental
health needs of the aged population in rural areas
efficiently and effectively.
Although our previous study of depression care man-
agement in urban Chinese primary care clinics produced
promising results for treatment of late life depression, it
was limited in a number of respects that the COACH
study will attempt to address. COACH is implemented
in rural villages, a necessary innovation given that 70%
of the older population lives in rural China. As well,
COACH incorporates a psychosocial dimension to care
with the AW that was lacking in previous work, couples
depression with care management of HTN to test the
model’s impacts on commonly comorbid chronic condi-
tions, and will contribute to understanding the role that
adherence plays in chronic disease management.
Successful dissemination of the COACH model to
other counties and provinces in China, and to other
rural LMIC settings, will require that it is more effective
than eCAU in reducing depressive symptoms, improving
quality of life, and improving BP control. It will require
that the delivery model be acceptable to multiple stake-
holders in diverse sociocultural contexts, including the
patients and their families, PCPs and other team mem-
bers, village leaders and those who administer the health
and aging services systems. To that end, COACH is
designed to leverage indigenous village resources to
contain costs and to meet the needs of village residents
and providers in a manner that is culturally congruent.
Successful dissemination will also require that the model
be affordable, for which this study will provide some pre-
liminary evidence. Nonetheless, additional modifications
will likely be needed, for example, by linking the COACH
teams to psychiatric supports using telehealth technology,
and telementoring using the Project ECHO® model to
build the teams’ expertise over time, reducing the need for
ongoing support and improving cost efficiency. With
these additional steps, Zhejiang Provincial officials may
support further testing on a larger scale.
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